Cite pubblico
[search 0]
Altro
Scarica l'app!
show episodes
 
Artwork
 
Experts shape our world. Sometimes for better, sometimes for worse. In every big story, you’ll find one; you’ll find a researcher, scientist, engineer, planner, policy wonk, data nerd, bureaucrat, regulator, intellectual, or pseudo-intellectual. Their ideas are often opaque, unrecognized, and difficult to understand. Some of them like it that way. On Cited, we reveal their hidden stories.
  continue reading
 
Artwork
 
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
  continue reading
 
Artwork

1
In Plain Cite

Federal Public Defender, WVS - A Federal Criminal Law Podcast

Unsubscribe
Unsubscribe
Ogni mese
 
In Plain Cite is a podcast about developments in federal criminal defense law, focusing on the US Supreme Court and the Fourth Circuit Court of Appeals, produced by the Federal Public Defender Office in the Southern District of West Virginia.
  continue reading
 
Cité Radieuse c’est quoi ? Une rencontre, une conversation avec des personnes inspirantes venant d’horizons très divers mais qui ont en commun de faire rayonner une ville : Marseille ! Elles y vivent, y ont vécu ou tout simplement l’aiment pour ce qu’elle a à offrir : Marseille est lumineuse, bouillonnante, arlequinée, agitée, on l’aime autant qu’on la déteste ... parfois ! Parfois seulement ! Je suis Caroline Bindel, journaliste basée à Marseille. Bienvenue dans Cité Radieuse ! Hébergé par ...
  continue reading
 
Artwork

1
Cited

Cited Media

Unsubscribe
Unsubscribe
Ogni mese
 
Experts shape our world. Sometimes for the better, sometimes for the worse. In every big story, you’ll find one; you’ll find a researcher, scientist, engineer, planner, policy wonk, data nerd, bureaucrat, regulator, intellectual, or pseudointellectual. Their ideas are often opaque, unrecognized, and difficult to understand. Some of them like it that way. On Cited, we reveal their hidden stories.
  continue reading
 
Le sacré et la cité tente de répondre à de grandes questions touchant le phénomène religieux dans notre société. Des questions de fond posées avec ouverture et sans complaisance par la communicatrice en histoire Myriam Wojcik. Une série qui vise à briser certains mythes et tabous.
  continue reading
 
The Cite Black Women podcast is a periodic program with a simple message: Cite Black Women. We have been producing knowledge since we blessed this earth. We theorize, we innovate, we revolutionize the world. We do not need mediators. We do not need interpreters. It's time to disrupt the canon. It's time to upturn the erasures of history. It's time to give credit where credit is due. This bi-weekly podcast features reflections and conversations about the politics and praxis of acknowledging a ...
  continue reading
 
Artwork

1
The "Cite" of the Crime

Jeremy Lasnetski

Unsubscribe
Unsubscribe
Ogni mese
 
The "Cite of the Crime" Podcast is a biweekly Florida and Federal criminal case law update show for criminal defense attorneys, prosecutors, judges and anybody who is interested in criminal law case law in the Florida District Courts, the Florida Supreme Court, the Eleventh Circuit Court of Appeals and the U.S. Supreme Court. Each week, criminal defense attorney, Jeremy Lasnetski of Shorstein, Lasnetski, & Gihon reviews the previous weeks Florida DCA and Florida Supreme Court cases and in a ...
  continue reading
 
Loading …
show series
 
Très heureuse de recevoir enfin Ezéchiel au micro de Cité Radieuse ! Je dis « enfin » car nous envisageons d'enregistrer cet épisode depuis plus d'un an rien que ça ! Et puis et puis et puis c’est aujourd’hui et c’est finalement très bien comme ça ! Ezéchiel est journaliste gastronomique depuis plus de dix ans, créateur de la newsletter POMELO et a…
  continue reading
 
Pink Sheet reporter and editors discuss potential changes that the incoming Trump Administration could make on the FDA, as well as worries about political interference in decision-making, and policy and staffing changes.More On These Topics From The Pink SheetUS FDA’s Drug Approval Norms Could Be Upended In Second Trump Term: https://insights.citel…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 1 November 2024. In this episode: Lilly plans DTC tirzepatide ads; Pfizer’s Bourla defends strategy; expert views from BioFuture; China retains attractions for some; and AbbVie’s Aliada acquisition.Playlist: soundcloud.com/citelinesounds/sets/scrips-five-mu…
  continue reading
 
We’re on break this week as everyone gears up for, and puzzles through, the results of this week’s US election. We’ll be back with new content next week. However, we have an episode from the Darts and Letters archive that is especially relevant to our ongoing Cited season, the Use and Abuse of Economic Expertise. It’s about the shifting political d…
  continue reading
 
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら「Déjà Vu In England: Lilly’s Alzheimer’s Drug Kisunla Gets MHRA Yes, But NICE Says No(邦訳:アルツハイマー治療薬ケサンラ承認で議論再び、薬価負担に悩む英国)」URL:  https://insights.citeline.com/pink-sheet/geography/europe/united-kingdom/deja-vu-in-england-lillys-alzheim…
  continue reading
 
We look at the shifting landscape of economic thinking within the Democratic Party. First, historian Lily Geismer, author of Left Behind: The Democrats’ Failed Attempt to Solve Inequality, tells us the story of how the Democrats became captured by the Clintonian ‘Third Way.’ The Third Way argued that economic policy should move away from the sunset…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 25 October 2024. In this episode: Merck & Co’s Modifi acquisition; scenarios for new obesity drugs; Astellas gets US approval for claudin drug Vyloy; iTeos builds TIGIT lead; and execs discuss AI in clinical trials.https://insights.citeline.com/scrip/quick-…
  continue reading
 
Health technologies are revolutionizing the ways in which life sciences organizations develop and deliver life-saving treatments to patients. In particular, digital therapeutics have become a prominent area of focus due to their potential to improve outcomes while reducing patient burden. Norstella continues to be proponent for these innovative tec…
  continue reading
 
Economics sometimes feels like physics–so sturdy, so objective, and so immutable. Yet, behind every clean number or eye-popping graph, there is usually a rather messy story, a story shaped by values, interests, ideologies, and petty bureaucratic politics. In our new mini-series, the Use and Abuse of Economic Expertise, we tell the hidden stories of…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 18 October 2024. In this episode: J&J looks to Tremfya as Stelara declines; Pfizer’s Hympavzi may find hemophilia B niche; big pharma’s cell and gene therapy realities; M&A took a holiday in Q3; and last rites for Sanofi’s RIPK1 drug.https://insights.citeli…
  continue reading
 
Pink Sheet reporter and editors discuss an emerging pharma strategy to avoid Medicare price negotiations (:25), legal wrangling related to compounding GLP-1 drugs for obesity and diabetes (14:20), and the varying opinions of FDA officials on the acceptability of artificial intelligence models that are not fully explainable (29:08)#pharma #businessM…
  continue reading
 
빅파마들은 세포유전자 치료제를 출시하면서 이러한 치료의 비용과 복잡성이라는 현실적인 문제에 직면해 있습니다. 최근 개최된 메사 세포유전자 회의를 취재한 Scrip 기사를 요약한 내용입니다. https://scrip.citeline.com/SC151041/Big-Pharma-Faces-Cell-And-Gene-Therapy-Market-RealitiesPlaylist: soundcloud.com/citelinesounds/sets/korean-language-biopharma-miniDi Citeline
  continue reading
 
Dexter Yan回顾了他在国庆长假前和阿斯利康全球执行副总裁-生物制药研发负责人Sharon Barr的采访。此外,本期播客迎来了Citeline Insights团队在上海的新成员、资深记者Xu Hu。她分享了先为达生物伊诺格鲁肽的最新III期临床数据,以及中国律师对美国生物安全法案影响的分析。Di Citeline
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 11 October 2024. In this episode: making cell and gene therapies more accessible; Roche’s obesity plans; Biosecure and Indian firms; IPOs begin to recover; and Nxera looks to the future.https://scrip.citeline.com/SC151048/Quick-Listen-Scrips-Five-MustKnow-T…
  continue reading
 
Introduction: Pink Sheet reporter and editors discuss experts’ experience helping drug sponsors negotiate prices with CMS (:33) and the FDA’s proposal for a new pathway to update vaccines before a pandemic is declared (12:02).More On These Topics From The Pink Sheet:Perspectives From The Front Lines: Navigating The First Round Of Medicare Price Neg…
  continue reading
 
Thierry Reboul a été le Directeur exécutif des cérémonies, des événements et de la marque Paris 2024 et le pilote de l’arrivée de la flamme à Marseille lors de ces merveilleux Jeux Olympiques sur notre sol. Avant cela il avait sa propre agence événementielle UBI BENE spécialisée dans les coups d’éclats, déjà ! On lui doit également, entre autres, l…
  continue reading
 
In the latest episode of the In Vivo podcast, Russ Lebovitz, the co-founder and scientist behind Amprion, a diagnostics company, discusses the role of alpha-synuclein misfolding in neurodegenerative diseases and how early alpha-synuclein detection has the potential to mitigate the impacts of diseases ranging from Parkinson's disease to Lewy body de…
  continue reading
 
Discover the game-changing insights from the LSX World Congress USA!Join Janelle Hart, Managing Editor at Citeline, a Norstella Company, as she explores the key takeaways from the LSX World Congress USA meeting. In this episode, Janelle sits down with Tony Shi, Principal and Head of Digital Health and Access Innovation Strategy, and Eric Boyda, Con…
  continue reading
 
Pink Sheet reporters and editors discuss Pfizer’s abrupt decision to withdraw Oxbryta (:32), the US FDA’s Oncologic Drugs Advisory Committee bringing sponsors of approved products back to discuss labeling changes while competitors are pending (10:46), and the new CEO of a generic industry trade association (27:34).More On These Topics From The Pink…
  continue reading
 
In this podcast, Andrew Warmington, Manufacturing Editor, Citeline, joins together with industry experts, Simone Secchi, R&D Process Chemist, Olon Group, and Matthieu Culie, Head of Development and GMP Manufacturing, GTP Bioways, Olon Group, to discuss the challenges in the development and manufacturing of ADCs.…
  continue reading
 
Emma Wille chats with oncology team director Dana Gheorghe, PhD, about the resurgence of radiopharmaceutical therapies in oncology.Other platforms (in addition to SoundCloud):​Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836​Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZ…
  continue reading
 
In this podcast, Janelle Hart, Managing Editor at Citeline, teams up with industry experts Mai Yee Mishir, Senior Director of Global Regulatory Affairs, and Sally-Ann McDowell, Senior Director of Clinical Development Strategy at Advanced Clinical, to discuss the vital role of HRQoL in clinical trials. Listen now.…
  continue reading
 
In this episode, HBW chats with Neil D’Souza, CEO of Makersite GmbH, a Stuttgart, Germany-based data software company that offers product data management tools that enable personal care firms to manage product sustainability, cost and compliance. D’Souza provides his take on what defines sustainable product development and how companies can use tec…
  continue reading
 
Introduction: Pink Sheet reporter and editor discuss the FDA’s latest advertising enforcement letter, which targeted a migraine treatment TV commercial featuring Serena Williams, and its impact on drug promotion (:36), as well as the now growing list of legal cases targeting agency decisions with Chevron deference overturned (13:32).More On These T…
  continue reading
 
Emma and Summer meet with oncology analyst Flora to discuss the therapeutic potential of exploring the tumor microenvironment.Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836​Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjEwNjU…
  continue reading
 
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら「Multiple Chinese Firms Expand Global Phase III Trials To Japan(邦訳:中国企業、第三相グローバル治験の地域を続々と日本に拡大)」 https://scrip.citeline.com/SC150842/Multiple-Chinese-Firms-Expand-Global-Phase-III-Trials-To-JapanPlaylist: https://soundcloud.com/citeli…
  continue reading
 
호아킨 두아토 존슨앤존슨 대표가 모건스탠리 헬스케어 컨퍼런스에서 발표한 내용입니다.https://scrip.citeline.com/SC150846/JJ-Interested-In-Differentiated-Obesity-AssetsPlaylist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-miniDi Citeline
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 6 September 2024. In this episode: J&J interested in differentiated obesity assets; Kerendia hits in heart failure; strong HERCULES data keep Sanofi’s MS plans alive; WCLC preview; and Mankind sets eyes on 5x growth.https://scrip.citeline.com/SC150865/Quick…
  continue reading
 
Pink Sheet reporter and editors discuss the potential fallout if the US FDA’s rare pediatric disease priority review voucher program is allowed to sunset on 1 October (:30), as well as an upcoming agency advisory committee meeting on potentially banning compounding of the now withdrawn pre-term birth prevention drug Makena (18:39).More On These Top…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 30 August 2024. In this episode: summer ADC dealmaking continues apace; a look at cell therapies in Japan; Pfizer’s new US digital consumer platform; Galapagos’s US point of care CAR-T study; and Novartis partners with Lindy on biologics delivery.https://sc…
  continue reading
 
Pink Sheet reporter and editors discuss new developments in the FDA’s plans to regulate artificial intelligence and drugs associated with it, including a new AI Council within CDER, as well as some of the unanswered questions about AI in drug development.More On These Topics From The Pink Sheet Artificial Intelligence: CDER’s New Council Takes Char…
  continue reading
 
In this week’s Digital Health Roundup, Medtech Insight’s Ryan Nelson highlights Click Therapeutics’ FDA-cleared digital therapeutics (DTx) for depression and Sinaptica Therapeutics’ personalized neuromodulation for Alzheimer’s patients. Marion Webb discusses her interview with MindMaze’s John Krakauer on their gaming-focused DTx to help people reco…
  continue reading
 
Loading …

Guida rapida